Nov 16–20, 2013
Dallas Convention Center
Join or renew your AHA/ASA Professional Membership today to save on registration
for all AHA Scientific Sessions.
Saturday, Nov. 16, 2013
8:00 a.m. – 5:00 p.m.
Location – Dallas Convention Center, Ballroom A1
Registration -- Opens June 12, 2013
This workshop is designed to enable vascular and cardiovascular post-graduate trainees and junior faculty to more effectively identify and treat peripheral vascular disorders and, by so doing, reduce death and disability from arteriosclerosis and venous thrombosis. The workshop brings together trainees from diverse disciplines, including cardiovascular and vascular medicine, vascular surgery, and interventional cardiology and interventional radiology to facilitate discussion of the common evidence base practices. It also fosters the commitment of participants to the lifelong creation of cooperative and mutually supportive clinical environments, thus promoting the use of cost-effective, evidence-based diagnostic and therapeutic management strategies for patients with peripheral vascular disorders.
After participating in this activity, participants should be able to:
- Describe the epidemiology, diagnostic approaches, and most effective management for PAD.
- Discuss the outcomes of the CLEVER trial and potential ramifications for PAD treatment.
- Describe gender differences in the prevalence, risk factors, presentation, and outcomes of PAD as well as current unmet needs in the management and treatment of women.
- Describe evidence-based recommendations designed to prevent secondary cardiovascular events in patients with PAD and opportunities to implement them in clinical practice.
- Discuss current understanding of CLI and limitations of current therapies.
- Discuss the results of studies comparing EVAR with open repair of AAA and their implications for patient selection and management approaches.
- Describe the most appropriate patients for renal artery stenting and the risks and benefits of endovascular approaches vs medical approaches.
- Discuss the risks and benefits of medical therapy versus interventional approaches in patients with carotid artery disease.
- Describe current best practices, controversies, new clinical evidence, and ongoing trials in the area of thrombolytic therapy for the treatment of VTE.
- Describe the potential risks and benefits of newly approved oral anticoagulants for the prophylaxis and treatment of VTE and their place in the armamentarium for preventing and treating this condition.
The workshop is designed for trainees (junior faculty, fellows, residents, students) from multiple disciplines relevant to vascular medicine (including cardiovascular and vascular medicine), cardiovascular radiology, vascular surgery, and interventional radiology. Lectures will be delivered by international experts in vascular diseases.
Should you attend? View the preliminary program to help you decide, then sign up today!